Lipoprotein a: An emerging risk identifier and evolving clinical target

Lipoprotein a: An emerging risk identifier and evolving clinical target

Pathophysiology, epidemiology and genetics data support the causal role of Lipoprotein a, Lp(a), in cardiovascular disease, and in aortic valve calcification and stenosis. Increased levels of Lp(a) are the most prominent single gene lipid disorder worldwide since 1.4 billion people present Lp(a) val...

Full description

Bibliographic Details
Main Authors: Konstantinos Tsarouhas*, Athanasios Hoursalas*, Alexander I. Vardavas, Christina Tsitsimpikou
Format: Article
Language:English
Published: European Publishing 2022-02-01
Series:Public Health and Toxicology
Subjects:
cardiovascular diseases
lipoprotein a
kringles
antisense nucleotides therapy
risk marker
Online Access:http://www.publichealthtoxicology.com/Lipoprotein-a-An-emerging-risk-identifier-and-evolving-clinical-target,145601,0,2.html

Internet

http://www.publichealthtoxicology.com/Lipoprotein-a-An-emerging-risk-identifier-and-evolving-clinical-target,145601,0,2.html

Similar Items